Your browser doesn't support javascript.
loading
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial.
Barata, Pedro C; Chehrazi-Raffle, Alexander; Allman, Kimberly D; Asnis-Alibozek, Aviva; Kasturi, Vijay; Pal, Sumanta K.
Afiliação
  • Barata PC; Department of Medicine, Case Comprehensive Cancer Center, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
  • Chehrazi-Raffle A; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Allman KD; AVEO Oncology, an LG Chem Company, Boston, MA, USA.
  • Asnis-Alibozek A; AVEO Oncology, an LG Chem Company, Boston, MA, USA.
  • Kasturi V; AVEO Oncology, an LG Chem Company, Boston, MA, USA.
  • Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Oncologist ; 28(10): 894-900, 2023 10 03.
Article em En | MEDLINE | ID: mdl-37315114
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article